An Experimental Study into the Photodynamic/Sonodynamic Therapy of Triple-Negative Breast Cancer Mediated by the Novel Nano-Photonic Sensitizer NBDPBr Nanoparticles

Purpose: This study aimed to develop a synergistic photodynamic therapy/sonodynamic therapy (PDT/SDT) system that utilises novel NBDPBr nanoparticles (NPs). These NBDPBr NPs are composed of the aza-boron-dipyrromethene (Aza-BODIPY) dye NBDPBr, which is encapsulated in amphiphilic polymer F-127 (Pluronic ® ). The system is intended for the treatment of triple-negative breast cancer (TNBC), and simultaneously establishes a multimodal imaging platform for real-time monitoring of the therapeutic effect. Methods: The photophysical properties of the NBDPBr NPs were characterised. Singlet oxygen ( 1 O 2 ) generation was assessed under laser (L) and ultrasound (US) irradiation. In vitro cytotoxicity and reactive oxygen species (ROS) production were evaluated in 4T1 TNBC cells. The therapeutic effect and biosafety in vivo were tested by using a syngeneic TNBC mouse model, and it was monitored by ultra-resolution micro-imaging (URM) and photoacoustic imaging (PAI). Results: The spherical NBDPBr NPs showed excellent stability, with an average diameter of about 82.9 nm. Combined laser and ultrasound irradiation induced the highest 1 O 2 production, leading to 96.02% cell death in vitro and near-complete tumor suppression in vivo, with no significant systemic toxicity. URM revealed decreased tumor microvascular density and PAI indicated reduced blood oxygen saturation post-treatment, confirming synergistic PDT/SDT-induced vascular disruption and tumor hypoxia. Conclusion: NBDPBr NPs mediate potent synergistic PDT/SDT against TNBC, supported by a dual-modal URM/PAI imaging platform for treatment monitoring. This study presents a promising theranostic strategy with high translational potential for TNBC management. Keywords: photosensitizers, nanoparticle, photodynamic therapy, sonodynamic therapy, triple-negative breast cancer, multimodal imaging, synergistic therapy

Authors

Institutions

Publication Details

Journal
International Journal of Nanomedicine
Published
2026-03-01
DOI
https://doi.org/10.2147/ijn.s576927
Primary Topic
Nanoplatforms for cancer theranostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An Experimental Study into the Photodynamic/Sonodynamic Therapy of Triple-Negative Breast Cancer Mediated by the Novel Nano-Photonic Sensitizer NBDPBr Nanoparticles

Lilin Zhao, Leichen Wang, Yaqi Zhang, Qian Huang et al.
International Journal of Nanomedicine
Nanoplatforms for cancer theranostics
article

An Experimental Study into the Photodynamic/Sonodynamic Therapy of Triple-Negative Breast Cancer Mediated by the Novel Nano-Photonic Sensitizer NBDPBr Nanoparticles

Lilin Zhao, Leichen Wang, Yaqi Zhang, Qian Huang, Ting Rui Zhang
article en

Abstract

Purpose: This study aimed to develop a synergistic photodynamic therapy/sonodynamic therapy (PDT/SDT) system that utilises novel NBDPBr nanoparticles (NPs). These NBDPBr NPs are composed of the aza-boron-dipyrromethene (Aza-BODIPY) dye NBDPBr, which is encapsulated in amphiphilic polymer F-127 (Pluronic ® ). The system is intended for the treatment of triple-negative breast cancer (TNBC), and simultaneously establishes a multimodal imaging platform for real-time monitoring of the therapeutic effect. Methods: The photophysical properties of the NBDPBr NPs were characterised. Singlet oxygen ( 1 O 2 ) generation was assessed under laser (L) and ultrasound (US) irradiation. In vitro cytotoxicity and reactive oxygen species (ROS) production were evaluated in 4T1 TNBC cells. The therapeutic effect and biosafety in vivo were tested by using a syngeneic TNBC mouse model, and it was monitored by ultra-resolution micro-imaging (URM) and photoacoustic imaging (PAI). Results: The spherical NBDPBr NPs showed excellent stability, with an average diameter of about 82.9 nm. Combined laser and ultrasound irradiation induced the highest 1 O 2 production, leading to 96.02% cell death in vitro and near-complete tumor suppression in vivo, with no significant systemic toxicity. URM revealed decreased tumor microvascular density and PAI indicated reduced blood oxygen saturation post-treatment, confirming synergistic PDT/SDT-induced vascular disruption and tumor hypoxia. Conclusion: NBDPBr NPs mediate potent synergistic PDT/SDT against TNBC, supported by a dual-modal URM/PAI imaging platform for treatment monitoring. This study presents a promising theranostic strategy with high translational potential for TNBC management. Keywords: photosensitizers, nanoparticle, photodynamic therapy, sonodynamic therapy, triple-negative breast cancer, multimodal imaging, synergistic therapy

International Journal of NanomedicineVol. Volume 21
Nanjing Tech University (CN), Jiangsu Cancer Hospital (CN)
Good health and well-being
Openalex Percentile: Top 5%
Nanoplatforms for cancer theranostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.